NewcelX Ltd. (NCEL)
NASDAQ: NCEL · Real-Time Price · USD
2.540
-0.150 (-5.58%)
At close: Nov 20, 2026, 4:00 PM EST
2.480
-0.060 (-2.36%)
After-hours: Nov 20, 2026, 7:30 PM EST
NewcelX Market Cap
NewcelX has a market cap or net worth of $14.67 million as of November 20, 2026. It is the 38,620th most valuable company in the world and the 5,265th biggest in the United States. Its market cap has decreased by 2.76% in one year.
Market Cap
14.67M
Enterprise Value
14.35M
1-Year Change
-2.76%
Global Rank
Country Rank
#5,265 United States
Category
ChartMarket Cap Chart
Since October 31, 2025, NewcelX's market cap has decreased from $33.23M to $14.67M, a decrease of -55.85%. That is a compound annual growth rate of -53.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 14.67M | 69.40% |
| Dec 31, 2025 | 8.66M | -73.94% |
| Oct 31, 2025 | 33.23M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pasithea Therapeutics | 16.00M |
| Atossa Therapeutics | 15.92M |
| Quoin Pharmaceuticals | 15.76M |
| Celularity | 15.02M |
| Context Therapeutics | 14.70M |
| Estrella Immunopharma | 13.96M |
| Citius Pharmaceuticals | 13.96M |
| BeyondSpring | 13.57M |